NASDAQ · PRVA

Privia Health Group, Inc.

Healthcare · Medical - Healthcare Information Services

$20.22▼ 0.76% ($0.15)today

As of 11:23 AM ET

52-week

$19.53$28.82

Market cap

$2.55B

What the market price implies · Reverse DCF

Historical revenue grew by 21.75%/yr over the past 4 years.

Selected forecast · Base scenario

13.87%/yr · actual 10-year annualized revenue growth

Year 1 growth: 21.78%

Market-implied · Base operating assumptions + edited margins

Unavailable · flat 10-year annualized revenue growth

Reverse DCF solves revenue growth itself using Base operating assumptions and your edited margins. Changing forecast growth alone does not change the implied rate. This is a model-implied requirement, not an analyst forecast.

No supported revenue growth rate matches this price with these operating assumptions.

Valuation

Recommended · Revenue & margin DCF

Price used

$20.22

Estimated value / share

$2,671.80

Base scenario

This estimate is 13,116.91% above the price used.

USD · TTM ending 2026-06-30

The discount rate uses the model's minimum bound. Limited beta or capital-structure data may affect this estimate.

This estimate is at least 3× the price used. Review the growth, margin and investment assumptions behind the gap.

Year 1 growth 21.78% · Ending margin 2.19% · Discount rate 5.44%

Assumption scenarios, not statistical confidence intervals.

Method, dates & sources

Estimated from future revenue, operating margins, and the investment needed to support them.

Price timestamp: Sep 17, 2026, 3:23 PM UTC
Financial statement period: TTM ending 2026-06-30
Data refreshed: Sep 17, 2026, 3:23 PM UTC · provider

Why this method?

FCFF is positive, but it is still too unstable and too short-lived to anchor even a normalized FCFF DCF. Use revenue and margin assumptions instead of compounding current FCFF.

Is FCFF positive and has it been for 3+ consecutive years? 3 consecutive positive FCFF years are available.

Is FCFF stable (not swinging >30% year to year)? The largest recent FCFF swing is 243.0%. Latest capex is 3.6x the prior median, which points to a capex supercycle that should be normalized first.

Do you have 5+ years of positive FCFF history? Only 3 consecutive positive FCFF years are available.

Price vs Fundamentals

Why The Stock Is Moving

Mixed / unclearLow confidence

1Y Price: -8.98%Revenue (TTM): 24.1%FCF (TTM): -152.53%P/FCF: 0th pct

What changed

The stock fell 8.98% over the last year. Revenue grew 24.1% over the trailing twelve months. Operating margin moved from 1.03% to 1.9%. Free cash flow declined 152.53% over the trailing twelve months.

What the market seems to be pricing

The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.

What would invalidate this read

Operating margin currently stands at 1.9%. A decisive move in revenue — currently up 24.1% — would be the clearest signal to resolve the ambiguity.

Performance

Return analysis

Company profile

Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States.

CEOParth Mehrotra

SectorHealthcare

IndustryMedical - Healthcare Information Services

Employees1,226

IPO dateApr 28, 2021

https://www.priviahealth.com

Market multiples

Forward P/E—

EV/EBITDA45.07

Enterprise value$2.43B

Stock splits

No stock splits recorded for this ticker.

Profitability & growth

Revenue growth21.39%

Gross margin (FY2025)9.87%▼0.3ppvs FY2024

Operating margin (FY2025)1.61%▲0.6ppvs FY2024

ROEN/A

Analyst consensus

RatingBuy

Target price$27.33▲35.20%

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 5, 2026

Q4 FY26 · EPS est $0.09 · Revenue est $610.63M

View